Derivation of iPS cell line (ICGi032-A) from a patient affected with fragile X syndrome

Stem Cell Research - Tập 57 - Trang 102615 - 2021
M.M. Gridina1, E.M. Shitik2, N.A. Lemskaya3, J.M. Minina1, I.V. Grishchenko2, A.A. Dolskiy2, A.R. Shorina4, Y.V. Maksimova4,5, D.V. Yudkin2
1Institute of Cytology and Genetics SB RAS, Novosibirsk, Russia
2State Research Center of Virology and Biotechnology “Vector”, Federal Service for Surveillance on Consumer Rights Protection and Human Well-being (FBRI SRC VB “Vector”, Rospotrebnadzor), Koltsovo, Novosibirsk Region, Russia
3Institute of Molecular and Cellular Biology SB RAS, Novosibirsk, Russia
4SBIH Novosibirsk Municipal Clinical Hospital №1, Novosibirsk, Russia
5Novosibirsk State Medical University, Novosibirsk, Russia

Tài liệu tham khảo

Lemskaya, 2018, A modified protocol for highly efficient EBV-mediated immortalization of human B lymphocytes from small volumes of peripheral blood serum, Egpt. J. Med. Hum. Genet., 19, 221, 10.1016/j.ejmhg.2017.10.002 Nikitina, 2018, Induced pluripotent stem cell line, IMGTi003-A, derived from skin fibroblasts of an intellectually disabled patient with ring chromosome 13, Stem Cell Res., 33, 260, 10.1016/j.scr.2018.11.009 Okita, 2013, An efficient nonviral method to generateintegration-free human-induced pluripotent stem cells from cord blood andperipheral blood cells, Stem Cells, 31, 458, 10.1002/stem.1293